| 論文 |
papers |
-
Donor lymphocyte infusion-based therapy for relapsed adult T-cell leukemia/lymphoma after HLA-haploidentical hematopoietic stem cell transplantation. Shinichi Katsuoka,Hidehiro Itonaga,Miki Hashimoto,Hikaru Sakamoto,Takafumi Furumoto,Yuichi Yamada,Takeharu Kato,Makiko Horai,Shinya Sato,Koji Ando,Kazuhiro Nagai,Nariyoshi Matsumoto,Daisuke Sasaki,Hiroo Hasegawa,Yoshitaka Imaizumi,Katsunori Yanagihara,Yasushi Miyazaki Transplant immunology 92巻102262頁-102262頁 2025年09月
-
Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine Monotherapy. Takafumi Furumoto,Koji Ando,Eo Toriyama,Tomoko Hata,Shinichi Katsuoka,Saori Nishimura,Masamitsu Ichinose,Miki Hashimoto,Machiko Fujioka,Chika Sakaki,Hikaru Sakamoto,Masahiko Chiwata,Rena Kamijo,Yuji Kobayashi,Hideaki Kitanosono,Jun Nakashima,Takeharu Kato,Masataka Taguchi,Makiko Horai,Masatoshi Matsuo,Junya Makiyama,Hidehiro Itonaga,Shinya Sato,Maki Baba,Yasushi Sawayama,Yumi Takasaki,Jun Taguchi,Daisuke Imanishi,Yoshitaka Imaizumi,Yasuhisa Kawaguchi,Hideki Tsushima,Tatsuro Jo,Shinichiro Yoshida,Yukiyoshi Moriuchi,Yasushi Miyazaki Internal medicine (Tokyo, Japan) 2025年07月10日
-
Improved survival among elderly patients with aggressive adult T-cell leukemia/lymphoma: Impact of mogamulizumab-containing chemotherapy. Miki Hashimoto,Takeharu Kato,Kenichi Yokota,Hikaru Sakamoto,Makiko Horai,Masataka Taguchi,Hidehiro Itonaga,Shinya Sato,Maki Baba,Koji Ando,Yoshitaka Imaizumi,Yasushi Miyazaki International journal of hematology 120巻6号694頁-704頁 2024年12月
-
RAISING revealed a heterogenous pattern of HTLV-1 clonality after HLA-haploidentical peripheral blood stem cell transplantation for ATL. Hidehiro Itonaga,Takeharu Kato,Yasushi Sawayama,Shinichi Katsuoka,Takafumi Furumoto,Nariyoshi Matsumoto,Daisuke Sasaki,Yuichi Yamada,Miki Hashimoto,Machiko Fujioka,Hikaru Sakamoto,Hiroo Hasegawa,Yoshitaka Imaizumi,Kazuhiro Nagai,Katsunori Yanagihara,Yasushi Miyazaki Leukemia & lymphoma 65巻2号275頁-278頁 2024年02月
-
Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group. Masahiko Chiwata,Hidehiro Itonaga,Shinya Sato,Miki Hashimoto,Machiko Fujioka,Sachie Kasai,Hikaru Sakamoto,Eo Toriyama,Jun Nakashima,Rena Kamijo,Hideaki Kitanosono,Yuji Kobayashi,Makiko Horai,Masataka Taguchi,Masatoshi Matsuo,Junya Makiyama,Yumi Takasaki,Emi Matsuo,Kensuke Horio,Koji Ando,Yasushi Sawayama,Jun Taguchi,Yasuhisa Kawaguchi,Hideki Tsushima,Daisuke Imanishi,Yoshitaka Imaizumi,Shinichiro Yoshida,Tatsuro Jo,Hiroaki Nonaka,Yukiyoshi Moriuchi,Kazuhiro Nagai,Ken-Ichi Yokota,Tomoko Hata,Yasushi Miyazaki Internal medicine (Tokyo, Japan) 60巻14号2207頁-2216頁 2021年07月15日
-
Donor lymphocyte infusion-based therapy for relapsed adult T-cell leukemia/lymphoma after HLA-haploidentical hematopoietic stem cell transplantation. Shinichi Katsuoka,Hidehiro Itonaga,Miki Hashimoto,Hikaru Sakamoto,Takafumi Furumoto,Yuichi Yamada,Takeharu Kato,Makiko Horai,Shinya Sato,Koji Ando,Kazuhiro Nagai,Nariyoshi Matsumoto,Daisuke Sasaki,Hiroo Hasegawa,Yoshitaka Imaizumi,Katsunori Yanagihara,Yasushi Miyazaki Transplant immunology 92.102262-102262 2025/09
-
Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine Monotherapy. Takafumi Furumoto,Koji Ando,Eo Toriyama,Tomoko Hata,Shinichi Katsuoka,Saori Nishimura,Masamitsu Ichinose,Miki Hashimoto,Machiko Fujioka,Chika Sakaki,Hikaru Sakamoto,Masahiko Chiwata,Rena Kamijo,Yuji Kobayashi,Hideaki Kitanosono,Jun Nakashima,Takeharu Kato,Masataka Taguchi,Makiko Horai,Masatoshi Matsuo,Junya Makiyama,Hidehiro Itonaga,Shinya Sato,Maki Baba,Yasushi Sawayama,Yumi Takasaki,Jun Taguchi,Daisuke Imanishi,Yoshitaka Imaizumi,Yasuhisa Kawaguchi,Hideki Tsushima,Tatsuro Jo,Shinichiro Yoshida,Yukiyoshi Moriuchi,Yasushi Miyazaki Internal medicine (Tokyo, Japan) 2025/07/10
-
Improved survival among elderly patients with aggressive adult T-cell leukemia/lymphoma: Impact of mogamulizumab-containing chemotherapy. Miki Hashimoto,Takeharu Kato,Kenichi Yokota,Hikaru Sakamoto,Makiko Horai,Masataka Taguchi,Hidehiro Itonaga,Shinya Sato,Maki Baba,Koji Ando,Yoshitaka Imaizumi,Yasushi Miyazaki International journal of hematology 120.6.694-704 2024/12
-
RAISING revealed a heterogenous pattern of HTLV-1 clonality after HLA-haploidentical peripheral blood stem cell transplantation for ATL. Hidehiro Itonaga,Takeharu Kato,Yasushi Sawayama,Shinichi Katsuoka,Takafumi Furumoto,Nariyoshi Matsumoto,Daisuke Sasaki,Yuichi Yamada,Miki Hashimoto,Machiko Fujioka,Hikaru Sakamoto,Hiroo Hasegawa,Yoshitaka Imaizumi,Kazuhiro Nagai,Katsunori Yanagihara,Yasushi Miyazaki Leukemia & lymphoma 65.2.275-278 2024/02
-
Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group. Masahiko Chiwata,Hidehiro Itonaga,Shinya Sato,Miki Hashimoto,Machiko Fujioka,Sachie Kasai,Hikaru Sakamoto,Eo Toriyama,Jun Nakashima,Rena Kamijo,Hideaki Kitanosono,Yuji Kobayashi,Makiko Horai,Masataka Taguchi,Masatoshi Matsuo,Junya Makiyama,Yumi Takasaki,Emi Matsuo,Kensuke Horio,Koji Ando,Yasushi Sawayama,Jun Taguchi,Yasuhisa Kawaguchi,Hideki Tsushima,Daisuke Imanishi,Yoshitaka Imaizumi,Shinichiro Yoshida,Tatsuro Jo,Hiroaki Nonaka,Yukiyoshi Moriuchi,Kazuhiro Nagai,Ken-Ichi Yokota,Tomoko Hata,Yasushi Miyazaki Internal medicine (Tokyo, Japan) 60.14.2207-2216 2021/07/15
|